Opening book details…
About this Medicine article
The First-line Treatment for Unresectable Hepatocellular Carcinoma Patients: Lenvatinib Versus Sorafenib, or Beyond? by Xie, Feihu; Feng, Shi; Sun, Lejia; Mao, Yilei is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Xie, Feihu; Feng, Shi; Sun, Lejia; Mao, Yilei
- Publisher
- AME Publishing Company (ISSN 2304-3881)
- Published
- 2018
- Field
- Medicine (Health Sciences)
More by Xie, Feihu; Feng, Shi; Sun, Lejia; Mao, Yilei
Browse all works by Xie, Feihu; Feng, Shi; Sun, Lejia; Mao, Yilei